Sizun Jiang, Ph.D.

Head of Scientific Advisory Board

Therapeutic Areas

Drug	Indication	Phase
Immune Suppression in EBV+ cHL	Classical Hodgkin Lymphoma	Research
ADC Resistance in Bladder Cancer	Bladder Cancer	Research
Spatial Microenvironment in DLBCL	Diffuse Large B-Cell Lymphoma	Research
Ebola Virus-Host Interactions	Ebola Virus Infection	Research